These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 6368184)

  • 1. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Mar; 27(3):194-209. PubMed ID: 6368184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sucralfate--alternative therapy for peptic-ulcer disease.
    Garnett WR
    Clin Pharm; 1982; 1(4):307-14. PubMed ID: 6764389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The other option in peptic ulcer therapy.
    Halter F
    S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology, clinical efficacy, and adverse effects of sucralfate, a nonsystemic agent for peptic ulcer.
    Spiro HM
    Pharmacotherapy; 1982; 2(2):67-71. PubMed ID: 6927335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study.
    Pop P; Nikkels RE; Thys O; Dorrestein GC
    Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate for peptic ulcer--a reappraisal.
    Med Lett Drugs Ther; 1984 Apr; 26(660):43-4. PubMed ID: 6323938
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of sucralfate in peptic disease.
    Jensen SL; Funch Jensen P
    Dig Dis; 1992; 10(3):153-61. PubMed ID: 1611711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse rates following initial ulcer healing with sucralfate and cimetidine.
    Marks IN; Wright JP; Lucke W; Girdwood AH
    Scand J Gastroenterol Suppl; 1983; 83():53-6. PubMed ID: 6579632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cimetidine and sucralfate in the treatment of bleeding peptic ulcers.
    Goldfarb JP; Czaja MJ
    Am J Gastroenterol; 1985 Jan; 80(1):5-7. PubMed ID: 3881014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH; Bighley LD; Iles RL
    J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sucralfate: development of a new concept of anti-ulcer treatment. Review of its pharmacodynamic properties].
    Gorget C
    Rev Med Interne; 1985 Jun; 6(3):313-9. PubMed ID: 3901171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Maintenance therapy of ulcer disease. Comparative multicenter study of sucralfate, cimetidine and a placebo].
    Jean F; Bonnefond A; Gislon J; Kloeti G; Libeskind M; Petite JP; Rautureau J; Roberti A; Zeitoun P
    Rev Med Interne; 1985 Jun; 6(3):321-6. PubMed ID: 3901172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sucralfate: the Bangkok review.
    Korman MG; Bolin TD; Szabo S; Hunt RH; Marks IN; Glise H
    J Gastroenterol Hepatol; 1994; 9(4):412-5. PubMed ID: 7948825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study.
    Classen M; Bethge H; Brunner G; Dirr B; Frotz H; Gabor M; Gail H; Grabner R; Hagenmüller F; Heinkel K
    Scand J Gastroenterol Suppl; 1983; 83():61-8. PubMed ID: 6356323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approach to ulcer healing.
    Blum AL
    Am J Med; 1985 Aug; 79(2C):8-14. PubMed ID: 2863981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.